Should We Overhaul the Drug Development and Pricing System?
Setup
The high cost of pharmaceuticals gets a lot of public attention, but that is only the endpoint of a long pipeline that moves drugs from the laboratory, to clinical testing, to approval, and into the marketplace. In the era of precision medicine, we urgently need a system that supports the development of innovative therapies at every step — but just as urgently, we need strategies that allow consumers to gain access to them at reasonable prices. Eminent health economists look into the heart of the drug discovery framework and answer the question patients care most about: Can the system work better so we can pay for the therapies we need?
Speakers
-
Len NicholsProfessor of Health Policy and Director, Center for Health Policy Rese... -
Margot Sanger-KatzHealth Care Correspondent, The New York Times -
Stacie DusetzinaProfessor at Vanderbilt University School of Medicine -
Craig GarthwaiteProfessor at Northwestern University’s Kellogg School of Management
- 2019 Health
Explore More
Economy
While the workforce is still adapting to the changing economic landscape, one thing is certain — the traditional blueprints for education and the workplace have been ripped up...
While the workforce is still adapting to the changing economic landscape, one thing is certain — the traditional blueprints for education and the workplace have been ripped up...
After two devastating years fighting the pandemic, how do we rebuild and support stronger health care and public health workforces? Dave Chokshi, who helped lead New York Cit...
